Current state and controversies in fertility preservation in women with breast cancer

doi:10.5306/wjco.v8.i3.241

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9815)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

637

WORD

389

HTML

6480

Figures (1-1)

141

Tables (1-3)

138

Sum=7785

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

923

Download

1107

Sum=2030

Jun 10, 2017 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (37)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Clin Oncol. Jun 10, 2017; 8(3): 241-248
Published online Jun 10, 2017. doi: 10.5306/wjco.v8.i3.241

Table 2 Common adjuvant chemotherapy regimens for breast cancer and their impact of fertility

Chemotherapy regimen	Risk of amenorrhea or infertility
Chemotherapy regimen	Age ≤ 35 yr	Age >35 yr
CMF	4%-40%	80%-100%
CEF	47%	80%-100%
CAF	No data	30%
AC	13.90%	68.20%
AC-T	9%-13%	65%-67%
AC-TH	0-14%	56%-67%

A: Doxorubicin; C: Cyclophosphamide; E: Epirubicin; F: 5-Fluorouracil; H: Trastuzumab; M: Methotrexate; T: Paclitaxel.

Citation: Taylan E, Oktay KH. Current state and controversies in fertility preservation in women with breast cancer. World J Clin Oncol 2017; 8(3): 241-248
URL: https://www.wjgnet.com/2218-4333/full/v8/i3/241.htm
DOI: https://dx.doi.org/10.5306/wjco.v8.i3.241